NCT06087861RecruitingPhase 2
5-Day Preoperative Radiation for Soft Tissue Sarcoma
Phase 2 5-Day Preoperative Radiation for Soft Tissue Sarcoma
Source: ClinicalTrials.gov · Last updated 10 Jun 2026
Brief summary (registry, in English)
The purpose of this study is to examine the safety and efficacy of an abbreviated course of preoperative radiation, given over five days, for patients with soft tissue sarcoma of the extremity, trunk or retroperitoneum. This is in contrast to standard preoperative radiation, which is given over 25 days.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- First submitted
- 11 Oct 2023
- Start date
- 6 Oct 2023
- Primary completion date
- Dec 2027
- Lead sponsor
- Stanford University
- Diseases
- Sarcoma
- NCT number
- NCT06087861
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 75
- From 6 Oct 2023 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of prior radiation to the area to be treated.
- Active use of other anti-cancer investigational agents.
- Planned use of concurrent chemotherapy, targeted therapy, or immunotherapy with radiation therapy (defined as the time interval starting 1 week before the first and last fraction of radiation therapy and surgery).
Other
- Pregnancy.
Who the study is looking for
- Histologically confirmed soft tissue sarcoma of the extremity, trunk or retroperitoneum.
- Has been offered preoperative radiation and surgery as part of standard-of-care treatment
- Age ≥ 18
- KPS ≥ 70 or ECOG 0 to 2
- Life expectancy ≥ 6 months
- If a woman is of childbearing potential, a negative serum or urine pregnancy test must be documented.
- Ability to understand and the willingness to personally sign the written IRB approved informed consent document.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University Coordinator of this site? Confirm its status | Palo Alto | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.